APLS-27.98%20.0%
ARQT+76.43%20.0%
CYTK+124.39%20.0%
HALO+34.13%20.0%
SPRY-70.19%20.0%
As of Aug 6, 2026, 4:25 AM ET
Biotech '25: Commercial / Late Stage Constituents
Apellis Pharmaceuticals, Inc.APLS | 20.0% | 0.00% | 0.00% | 0.00% | 0.00% | -31.97% | -18.46% | -25.70% | -27.98% | $2.19B |
Arcutis Biotherapeutics, Inc.ARQT | 20.0% | 4.11% | -0.91% | 3.95% | 0.89% | -6.68% | 0.48% | 63.25% | 76.43% | $3.39B |
ARS Pharmaceuticals, Inc.SPRY | 20.0% | 0.75% | -9.76% | -35.65% | 4.48% | -53.99% | -42.24% | -58.93% | -70.19% | $532.3M |
Cytokinetics, IncorporatedCYTK | 20.0% | 0.31% | -2.34% | -7.85% | 2.23% | 24.10% | 26.73% | 95.90% | 124.39% | $9.81B |
Halozyme Therapeutics, Inc.HALO | 20.0% | 0.43% | 2.03% | 3.48% | 1.27% | 24.21% | 20.22% | 32.64% | 34.13% | $9.91B |
| Theme return | — | 1.12% | -2.20% | -8.30% | 1.95% | -10.58% | -3.36% | 20.89% | 13.91% | — |
| Average | 20.0% | 1.12% | -2.20% | -7.21% | 1.77% | -8.87% | -2.65% | 21.43% | 27.36% | $5.17B |
| Median | 20.0% | 0.43% | -0.91% | 0.00% | 1.27% | -6.68% | 0.48% | 32.64% | 34.13% | $3.39B |
| Std Dev | 0.0% | 1.51% | 4.04% | 14.83% | 1.53% | 30.84% | 25.35% | 56.74% | 69.92% | $3.94B |
| Min | 20.0% | 0.00% | -9.76% | -35.65% | 0.00% | -53.99% | -42.24% | -58.93% | -70.19% | $532.3M |
| Max | 20.0% | 4.11% | 2.03% | 3.95% | 4.48% | 24.21% | 26.73% | 95.90% | 124.39% | $9.91B |
| % Positive Tickers | 80.00% | 20.00% | 40.00% | 80.00% | 40.00% | 60.00% | 60.00% | 60.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Biotech '25: Commercial / Late Stage tracks 5 publicly listed stocks in this theme: APLS, ARQT, CYTK, HALO, SPRY. See the constituent table for details.